Orthofix Medical Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Orthofix Medical Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Curacao
- Ticker symbol
- OFIX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000884624
Board of directors
-
Alan Lee Bazaar · DirectorSince 2023
-
Catherine M. Burzik · Director · Interim CEOSince 2023
-
Charles R. Kummeth · DirectorSince 2023
-
James F. Hinrichs · DirectorSince 2023
-
Jason Hannon · DirectorSince 2023
-
John B. Henneman III · DirectorSince 2023
-
Jon Carl Serbousek · Director · Executive ChairmanSince 2023
-
Keith Valentine · Director · President & CEOSince 2023
-
Lilly Marks · DirectorSince 2023
-
Massimo Calafiore · Director · President & CEOSince 2024
-
Michael E. Paolucci · DirectorSince 2023
-
Michael Finegan · DirectorSince 2023
-
Shweta Maniar · DirectorSince 2023
-
Stuart Essig · DirectorSince 2023
-
Thomas A. West · DirectorSince 2023
-
Vickie L. Capps · DirectorSince 2025
-
Wayne Burris · DirectorSince 2023
Chief executives
Dates unknown
Keith Valentine
· President & CEO
Since January 2023
Massimo Calafiore
· President & CEO
Until January 2023
· Former
Board connections
10 of this board's directors also sit on 19 other boards.
- via Keith Valentine and Thomas A. West
- via Keith Valentine
- via John B. Henneman III
- via John B. Henneman III
- via Catherine M. Burzik
- via Charles R. Kummeth
- via Thomas A. West
- via Alan Lee Bazaar
- via Charles R. Kummeth
- via Stuart Essig
- via Thomas A. West
- via James F. Hinrichs
- via Stuart Essig
- via Vickie L. Capps
- via James F. Hinrichs
- via Stuart Essig
- via Charles R. Kummeth
- via Keith Valentine
- via Shweta Maniar
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $4,091,867
- 16 purchases by 4 insiders
- Sold, last 12 months
- $6,603,732
- 27 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 21, 2026 | Juniper Investment Company, LLC 10% owner | Open-market sale | +190,000 | $8.86 | $1,683,381 |
| Sep 18, 2026 | Juniper Investment Company, LLC 10% owner | Open-market sale | +120,000 | $8.74 | $1,048,716 |
| Sep 1, 2026 | Fisher Patrick Officer (President, Global Limb Recon) | Open-market sale | −150 | $9.39 | $1,409 |
| Aug 18, 2026 | Fisher Patrick Officer (President, Global Limb Recon) | Open-market sale | −1,295 | $10.09 | $13,067 |
| Aug 17, 2026 | Juniper Investment Company, LLC 10% owner | Open-market sale | +20,000 | $10.01 | $200,260 |
| Aug 14, 2026 | Juniper Investment Company, LLC 10% owner | Open-market sale | +19,500 | $10.38 | $202,484 |
| Jun 18, 2026 | McPherron Aviva Officer (Pres, Global Ops & Qual) | Open-market sale | −3,670 | $9.38 | $34,425 |
| Jun 10, 2026 | Alan Lee Bazaar Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | Charles R. Kummeth Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | Jason Hannon Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | Michael Finegan Director | Grant or award | +20,721 | — | — |
| Jun 10, 2026 | Vickie L. Capps Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | John B. Henneman III Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | Wayne Burris Director | Grant or award | +14,965 | — | — |
| Jun 10, 2026 | Shweta Maniar Director | Grant or award | +14,965 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.